Anavex Life Profile

USD 0.01  0.37%

Purchase by Christopher Missling of 1450 shares of Anavex Life

Anavex Life Sciences Corp insider trading alert for perchase of common stock by Christopher Missling, President and CEO, on March 7, 2018. This event was filed by Anavex Life Sciences Corp with SEC on 2018-03-07. Statement of changes in beneficial ownership - SEC Form 4. Christopher Missling is currently serves as president ceo, cfo, treasurer, secretary, director of Anavex Life Sciences [view details]   

Anavex Life Summary

Anavex Life Sciences Corp (AVXL) is traded on Nasdaq Capital Markets in USA. It is located in NEW YORK, U.S.A and employs 10 people. Anavex Life is listed under Business Services category by Fama And French industry classification.The company currently falls under 'Small-Cap' category with current market capitalization of 119.01 M. Anavex Life Sciences Corp conducts business under Healthcare sector and is part of Business Services industry. This company has 44.57 M outstanding shares of which 4.13 M shares are presently shorted by private and institutional investors with about 11.28 trading days to cover. ANAVEX LIFE SCIEN currently holds about 28.05 M in cash with (9.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.63.
Check Anavex Life Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Selected Anavex Life Sciences Corp Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Anavex Life Against Markets

Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
< 83% 
Equity ratings for Anavex Life Sciences Corp are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of Alzheimers disease, other central nervous system diseases, pain, and various cancers. The company was founded in 2006 and is based in New York, New York. Anavex Life operates under Biotechnology classification in USA and traded on Nasdaq Capital Markets. It employs 10 people. more
Fama & French Business Services
Business Services
Fama & French Classification
NameAnavex Life Sciences Corp
CEOChristopher MisslingView All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock View All
RegionNorth America
LocationNEW YORK, U.S.A
Business Address51 West 52nd Street
ExchangeNasdaq Capital Markets
CIK Number01314052.0
IndustryBusiness Services
Contact Number844 689 3939
CurrencyUSD - US Dollar


Anavex Life Analyst Recommendations
Target PriceAdvice# of Analysts
13.67Strong Buy3Odds
Anavex Life Sciences Corp current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Anavex Life Analyst Advice  


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


Anavex Life Earnings Estimates
EPSEstimate Date
Quarterly Estimate-0.1May 10, 2017
Anavex Life Sciences Corp normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  


Anavex Life Corporate Directors
Elliot Favus Director, Ph.D
Athanasios Skarpelos Director
Bernd Metzner Director, Ph.D